Thrivent Financial for Lutherans
AZN icon

Thrivent Financial for Lutherans’s AstraZeneca AZN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.1M Buy
253,111
+233,446
+1,187% +$45M 0.09% 269
2025
Q4 		$3.63M Buy
19,665
+9,482
+93% +$1.66M 0.01% 1082
2025
Q3 		$1.56M Buy
10,183
+238
+2% +$36K ﹤0.01% 1498
2025
Q2 		$1.39M Sell
9,945
-1,545
-13% -$217K ﹤0.01% 1579
2025
Q1 		$1.49M Sell
11,490
-1,693
-13% -$245K ﹤0.01% 1450
2024
Q4 		$1.71M Sell
13,183
-9,045
-41% -$1.27M ﹤0.01% 1551
2024
Q3 		$3.46M Sell
22,228
-664,175
-97% -$107M 0.01% 1105
2024
Q2 		$107M Sell
686,403
-20,582
-3% -$3.1M 0.22% 113
2024
Q1 		$95.8M Buy
706,985
+190,919
+37% +$25.3M 0.19% 137
2023
Q4 		$69.5M Buy
516,066
+187,244
+57% +$24.3M 0.15% 193
2023
Q3 		$44.5M Sell
328,822
-1,572
-0.5% -$215K 0.11% 251
2023
Q2 		$47.3M Sell
330,394
-715,035
-68% -$105M 0.11% 243
2023
Q1 		$145M Buy
1,045,429
+418,822
+67% +$56.3M 0.35% 51
2022
Q4 		$85M Sell
626,607
-14,912
-2% -$1.87M 0.22% 120
2022
Q3 		$70.4M Buy
641,519
+1,115
+0.2% +$141K 0.19% 141
2022
Q2 		$84.6M Sell
640,404
-21,040
-3% -$2.76M 0.23% 105
2022
Q1 		$87.8M Buy
+661,444
New +$79.3M 0.17% 154
2017
Q4 		– Sell
-274
Closed -$18K – 2034
2017
Q3 		$18K Buy
+274
New +$17.3K ﹤0.01% 2090

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Thrivent Financial for Lutherans's AZN Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its AstraZeneca (AZN) stake by 1,187% in Q1 2026, buying an estimated $45M and bringing the position to 253,111 shares worth $49.1M. The position accounts for 0.09% of the portfolio, ranked #269.

Thrivent Financial for Lutherans first reported a position in AZN in Q3 2017 and has held it in 18 quarters since. The position peaked at $145M in Q1 2023. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Thrivent Financial for Lutherans held 253,111 shares of AstraZeneca worth $49.1M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 233,446 AstraZeneca shares in Q1 2026, an estimated $45M.
  • AstraZeneca made up 0.09% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #269 holding.
  • Thrivent Financial for Lutherans first reported a position in AstraZeneca in Q3 2017 and has held it in 18 quarters since.
  • Thrivent Financial for Lutherans's AstraZeneca position peaked at $145M in Q1 2023.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.